资讯

Investor's Business Daily on MSN48 分钟
Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global ...
Kiniksa stock rocketed 20% after first-quarter results on April 29. The biotech stock then broke out of a cup base with a buy ...